Candidature YC de LEAH Labs

Winter 2019Active

LEAH Labs a été sélectionné par Y Combinator dans le cadre du batch Winter 2019 en tant qu'entreprise Healthcare. Ci-dessous : ce que fait l'entreprise, qui l'a fondée, et sa candidature à YC, reconstruite question par question dans le vrai formulaire YC.

Batch YC: Winter 2019
Secteur d'activité: HealthcareTherapeutics
Taille de l'équipe: 4
Statut: Active
Lancé: 2018

Fondateurs

Wesley WiersonFounder

Ce que fait LEAH Labs

LEAH Labs is building living therapies for pets first, and their people next. We're first focused on CAR-T cell therapy for dogs with B cell lymphoma, the naturally occurring clinical analog of human non-Hodgkin's lymphoma. CAR-T cells are curative in humans, and our early results are showing the same - we're inducing remissions in pets with late stage lymphomas. Our virus-free gene editing platform allows us to engineer a dose of CAR-T cell therapy for ~$500, and brings the promise of a curative outcome. Given our safety and efficacy data to date, we believe this product could be used by general practice veterinarians, meaning we have thousands of customers all across the USA who typically treat with palliative care or refer cancer patients to specialty oncologists. Our CAR-T cell platform is regulated by the USDA, not the FDA, affording us a cost effective "full stack" to iterate and innovate on CAR-T cell therapy from a hypothesis through clinical validation.

Candidature YC de LEAH Labs, reconstruite

Candidature Y Combinator

LEAH Labs, promotion Winter 2019. Les vraies questions de candidature, répondues à partir de données publiques.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

LEAH Labs

Describe what your company does in 50 characters or less.

Living therapies for pets first, people next

What is your company going to make? Please describe your product and what it does or will do.

We are building virus-free CAR-T cell therapies specifically for dogs with B cell lymphoma. Our product engineers living therapeutic cells that induce remission in pets, and we plan to extend this platform to human treatments later. The platform is designed to be cost-effective and usable by general practice veterinarians, expanding access to curative therapies outside specialty clinics.

Where do you live now, and where would the company be based after YC?

We currently live and work in Minneapolis, MN, and the company will remain based there after YC.

Explain your decision regarding location.

Minneapolis has strong biotech resources and because our founders are here, it's practical and cost-effective to stay. Being under USDA regulation rather than FDA lets us iterate faster even from this location.

21 réponses supplémentaires dans la candidature complète

se trouvent dans la version complète. Créez un compte gratuit pour l'ouvrir dans YC Insights, à côté de tous les autres batches YC.

Voir la candidature complète

Questions fréquemment posées

Est-ce la vraie candidature YC de LEAH Labs ?

Non. Y Combinator garde les candidatures soumises privées. Ceci est une reconstruction : les vraies questions du formulaire YC, répondues à partir des données publiques de LEAH Labs (notes de lancement, parcours des fondateurs, description du produit). Cela montre comment une entreprise comme LEAH Labs se présenterait à YC, pas le texte qu'ils ont soumis.

À quel batch YC LEAH Labs appartenait-il ?

LEAH Labs faisait partie du batch Winter 2019 de Y Combinator.

Qui a fondé LEAH Labs ?

LEAH Labs a été fondé par Wesley Wierson.

Que fait LEAH Labs ?

Living therapies for pets first, and their people next

Comment lire la candidature complète reconstruite ?

Créez un compte Round Funded gratuit. La version complète de la candidature de LEAH Labs en 26 réponses, et de chaque autre promotion YC, se trouve dans YC Insights.